As only 50–60% of all AML are characterized by recurrent chromosomal translocations and gene mutations [6,18], attention has been pointed out to genes overly expressed by leukemia cells, such as Wilms’ tumor gene (WT1), as an alternative way to measure MRD [19,45]. The gene discussed is WT1; the disease is acute myeloid leukemia.